France to expand access to weight-loss drugs for obesity patients, AFP reports citing sources

Newsquawk StaffPublished On the live feed at 9 more headlines followed before this page went public
Newsquawk headlinesUTC

US 2-Year FRN Auction 0.089 (Prev. 0.103 )

European Closes: Euro Stoxx 50 +0.08% at 6,067, Dax 40 +0.13% at 25,218, FTSE 100 +0.13% at 10,505, CAC 40 +0.43% at 8,208, FTSE MIB -0.64% at 49,579, IBEX 35 +0.49% at 18,381, PSI -0.65% at 9,136, SMI +0.57% at 13,602, AEX -0.21% at 1,040

France to expand access to weight-loss drugs for obesity patients, AFP reports citing sources

White House says draft shown on Iran TV is incorrect; Trump will only agree to a deal that guarantees Iran will not have a nuclear weapon, JP reporter says

GE Aerospace (GE) says it is leaning toward high end of guidance range after a very strong Q1

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
  • France will soon reimburse 65% of the cost of weight-loss drugs Wegovy (NOVOB DC) and Mounjaro (LLY) for severely obese patients, two informed sources told AFP.
  • Health Minister to announce the scheme before its publication in the official journal of new legislation.

Related headlines

The whole workspace, free to try.

Try it free